ARDD2022 LMW Panel 2: Longevity medicine Therapeutics: Applied interventions, drug development, RCTs

Поделиться
HTML-код
  • Опубликовано: 4 окт 2024
  • ARDD2022 Is happy to present the second version of the longevity medicine workshop (LMW), an event exclusive to the ARDD that is tailored for clinicians and researchers alike, with the intention to connect the gap between wet lab research, insilico, and patient care. Definitely the best addition to the Longevity medicine course. Matt Kaberlein, Nir Barzilai, eric Verdin, Kristen Fortney, Alex Zhavoronkov, and Joan Mannick will be discussing the advances, technologies, challenges, and concerns regarding longevity medicine therapeutics: applied geroprotective interventions, drug repurposing and discovery development, and RCTs. #ARDD #ARDD2022 #longevity #LONGEVITYMEDICINE #drugdevelopment

Комментарии • 1

  • @peterz53
    @peterz53 Год назад

    Not to take away from the theme, but If governments would regulate the food industy in the same way as drugs (legal and illegal) the positive effects would leapfrog over many of the incremental changes of some of the drugs/supplements discussed here.